Eiry Roberts, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,914 shares at $140.79 ($410K) on 2024-01-31, disclosed to the SEC on 2024-02-02.
Scheduled sale ($410k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.79 | 1,457 | $205K | 50.0% |
| 2 | $140.79 | 1,457 | $205K | 50.0% |
| Total | $140.79 avg | 2,914 | $410K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-04 | $445K | — | Filing → |
| NBIX | SELL | 2024-02-15 | $296K | — | Filing → |
| NBIX | SELL | 2024-02-08 | $582K | — | Filing → |